Process key to pain management

Article

An optometrist's understanding of ocular pain management must always be evolving as you become more immersed in primary care, but, according to recent literature, most doctors under evaluate a patient's pain and discomfort and often don't prescribe enough medication.

Bruce E. Onofrey, OD, RPh, FAAO, clinical professor at the University Eye Institute of the University of Houston, provided an update on pain management, focusing on how optometrists can better understand and treat their patients' pain, and reviewed analgesics for ocular pain at the 3rd annual American Optometric Society meeting here in February.

"You should always be aware of the patient's pain," Dr. Onofrey said.

Acetaminophen

The mechanism of acetaminophen is not fully understood, but Dr. Onofrey noted it does lower fever without producing an anti-inflammatory effect or inhibiting platelets. It's often the drug of choice for children, pregnant women, and nursing mothers.

However, acetaminophen has also been associated with liver failure, he said. Those at greatest risk are children and adults who drink alcohol more than three times a day.

Opiates

Endogenous endorphins stimulate the morphine opioid receptors in the brain and spinal column. Opiates bind to these receptors and block the central pain receptors to produce an analgesic or sedative effect, Dr. Onofrey said. Schedule II opiates have high risk of abuse, while schedule V drugs have the lowest risk of abuse.

Common side effects of opiates include itching, nausea, urinary tract problems, drowsiness, and decreased respiration, according to Dr. Onofrey. "These are normal physiological responses," he said, and not the signs of an allergic reaction. Because opiates can decrease the respiratory rate, never prescribe them in a patient with chronic occlusive pulmonary disease or sleep apnea, he said.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Jessilin Quint, OD, MBA, FAAO, outlines her AOA's Optometry's Meeting 2025 presentation on nutrition and its impact on ocular health.
Carolyn Majcher, OD, FAAO, detailed a talk she gave alongside Mary Beth Yackey, OD, at Optometry's Meeting 2025.
Shelby Brogdon, OD, details opportunities for practices to answer the patient's concerns from the chair before they hit the internet for their contact lens needs.
Christi Closson, OD, FAAO, shares her excitement for the new Acuvue Oasys MAX 1-Day multifocal for astigmatism
Karen R. Hoffman, OD, shares how customizable scleral lenses can transform vision for patients with complex corneas, achieving 20/20 outcomes and enhanced comfort.
Janna Pham, OD, shares key takeaways from a corneal tomography session she presented alongside Travis Pfeifer, OD; and Matthew McGee, OD.
Jacob Lang, OD, FAAO, details early symptom relief demonstrated in as early as day 1 during AOA's Optometry's Meeting 2025.
When Langis Michaud, OD, MSc, FAAO, FSLS, FBCLA, FEAOO, began fitting scleral lenses 20 years ago, there was limited knowledge about conjunctival characteristics, scleral shape, and lens behavior.
Ioussifova details what sets Johnson & Johnson's new lens apart from the rest, which was launched at the American Optometric Association's Optometry's Meeting 2025.
Alongside Rachel Steele, OD, Rafieetary outlines what to look for in blurred disc margins and the importance of acting fast and sending patients to the ED when needed.
© 2025 MJH Life Sciences

All rights reserved.